Reta Pen 40mg

Description

The Reta Pen 40mg is a research-grade Retatrutide injection kit, engineered for precision in metabolic and obesity studies. Featuring 40 mg of high‑purity peptide (≥99% purity confirmed via Certificate of Analysis) and a pre‑filled injectable pen, the Reta Pen 40mg offers consistent dosing with minimal preparation

Retatrutide functions as a triple receptor agonist—targeting GLP‑1, GIP, and glucagon receptors—to support appetite suppression, enhance insulin sensitivity, and increase fat oxidation. Clinical phase 2 results showed up to ~24% body‑weight reduction over 48 weeks, making it one of the most powerful investigational peptides in metabolic research

Each Reta Pen 40mg kit includes one 40 mg pen, dosing by increment (2.5 mg–10 mg per week via click settings), a supply of disposable needles, and a user guide tailored for research protocols alluvi.org. Ideal for once-weekly administration, the pen simplifies studies requiring gradual dose escalation: start at 2.5 mg weekly, increasing to 5 mg, then up to 10 mg depending on protocol and tolerance

Store unopened Reta Pen 40mg refrigerated at 2–8 °C, protected from light. After first use, the pen may be stored at regulated room temperature for the manufacturer‑specified duration (typically up to 30 days) while maintaining sterility and efficacy

This kit is strictly for laboratory and preclinical use only; it is not approved or intended for human or veterinary consumption. Customers benefit from discreet packaging, tracked shipping, and full research support documentation. Purchase of the Reta Pen 40mg ensures dependable quality and streamlined dosing for sophisticated metabolic protocols.